Heart Failure Outcomes With Volume-Guided Management
Association Between Functional Impairment and Medication Burden in Adults with Heart Failure
Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure
Association of Abnormal Left Ventricular Functional Reserve With Outcome in Heart Failure With Preserved Ejection Fraction
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)